FU
Fulcrum Therapeutics, Inc.
FULC · NASDAQ
$3.84 +1.05% (+$0.04)
1M +0.00%
Market Cap $293.0M
P/E Ratio -
Div. Yield -
ROE 28.54%
Bulios Fair Price
$5.63
46.6% upside
Trenutna cena
$3.84
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica FULC trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.94x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 20.61%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 27.40%
ROE 28.54%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 31.35x
Int. coverage N/A
Stability
1 /100
Unstable Beta 3.00x
Rev. volatility 1,634.01%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o FULC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alexander C. Sapir
Employees
9
Headquarters
Cambridge
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report